✦ LIBER ✦

Multicenter phase II study of trastuzumab in combination with epirubicin and docetaxel as first-line treatment for HER2-overexpressing metastatic breast cancer

✍ Scribed by M. Venturini; C. Bighin; S. Monfardini; F. Cappuzzo; N. Olmeo; A. Durando; F. Puglisi; O. Nicoletto; A. Lambiase; L. Del Mastro

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II study of vinorelbine (alternati

✍ Mario Campone; Maria Blasinska-Morawiec; Anna Tekiela; Piotr Koralewski; Jean-Ch 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 297 KB

A phase II study of trastuzumab and cape

✍ Daigo Yamamoto; Satoru Iwase; Kaoru Kitamura; Hiroki Odagiri; Chizuko Yamamoto; 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 232 KB

Phase II study of capecitabine and trast

✍ Takanori Ishida; Takayoshi Kiba; Motohiro Takeda; Kotone Matsuyama; Satoshi Tera 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 367 KB

Randomized phase III trial of trastuzuma

✍ Kenichi Inoue; Kazuhiko Nakagami; Mitsuhiro Mizutani; Yasuo Hozumi; Yasuhiro Fuj 📂 Article 📅 2009 🏛 Springer US 🌐 English ⚖ 368 KB

Pegylated liposomal doxorubicin and tras

✍ Elmar Stickeler; Maximilian Klar; Dirk Watermann; Annette Geibel; Martha Földi; 📂 Article 📅 2009 🏛 Springer US 🌐 English ⚖ 276 KB

A multicenter randomized phase II study

✍ Jean-Yves Pierga; Suzette Delaloge; Marc Espié; Etienne Brain; Brigitte Sigal-Za 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 236 KB